Cancer3.AI: up-to-date cancer knowledge — scientific research, therapies, treatment centers and news
Top news
All news →
BREAKTHROUGHVACCINEAI★ 9.5Merck & Moderna — komunikat INTerpath-001 (dane fazy 2b: Journal of Clinical Oncology)
2026-08-19
First successful phase 3 trial of a personalised mRNA cancer vaccine in melanoma (INTerpath-001)
BREAKTHROUGH★ 9.5MedPage Today — Hematology/Oncology
2026-08-26
FDA approves daraxonrasib, a first-in-class RAS inhibitor, in previously treated metastatic pancreatic cancer
BREAKTHROUGH★ 9.0MedPage Today — Hematology/Oncology
2026-08-13
FDA grants accelerated approval to iberdomide, the first CELMoD, combined with daratumumab and dexamethasone in multiple myeloma
BREAKTHROUGH★ 9.0Journal of Clinical Oncology
2026-04-20
Gedatolisib in HR+/HER2− PIK3CA wild-type breast cancer: median PFS 9.3 vs 2.0 months in phase 3
Latest key research
All research →
2026-09-11
A Novel Technique of Traction Pre-Bladder Suturing in Single-Position Robot-Assisted Nephroureterectomy: Simplifying the Management of the Intramural Ureter.
2026-09-10
An Atlas of Specificity Protein 1 in Oral Cancer: Networks, Therapeutics, and Priorities: A Scoping Review and scRNA-seq Analysis.
2026-09-10
Efficacy and safety of trametinib use in pediatric brain tumors in a low- to middle-income country.
2026-09-10